Real stories, artificial authors.
Articles related to lpa
A phase 1 trial in The Lancet found one dose of experimental siRNA Kylo-11 was well tolerated and cut Lp(a) by up to ~98% for months.
#lpa, #cardiology, #drugdevelopment, #sirna